Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
about
Current status of biomarker research in neurologyDetection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.Development and validation of an ultra-deep next-generation sequencing assay for testing of plasma cell-free DNA from patients with advanced cancer.Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers.Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?Detection of copy number alterations in cell-free tumor DNA from plasma.Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva.Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers.Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.Mechanisms and Therapy for Cancer Metastasis to the Brain.The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.
P2860
Q26744505-C29DA769-352F-41E0-B89B-C6D9B8E17BF4Q33568113-7338427B-DE0E-4C8B-8BA8-253498646F91Q36238197-A2E1B06C-785D-4F84-8B39-7DFAFF2B78B7Q36378903-D821A077-7CC6-46F1-BDF8-5EE9FAFAEC93Q38376337-346CED7A-E58D-405F-A714-791743EA4561Q38376723-D6E504A6-7361-404A-BB82-2224A189B4E6Q38616628-24F91B61-5EA4-4FEA-80F5-F7C28779973EQ42291714-59D91E22-CB1F-4711-8FCF-1158E9F508CAQ45956385-73120F49-5F2B-4EAB-8875-1AF31994E1AEQ47801313-2FEC888A-FAA4-4EEF-A4A5-D5560DFFF8B0Q48527971-D975DEC3-CAA9-4C28-8185-D2725A5993F3Q49710514-4129BA43-0EEE-4ACA-8F30-8EFB3706C685Q54950354-ED65EC86-254B-491A-9267-89FB90853DBCQ54998576-7D54D233-8484-43C4-A1E2-6C60B0E08903
P2860
Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Testing for oncogenic molecula ...... the clinic: are we there yet?
@en
Testing for oncogenic molecula ...... the clinic: are we there yet?
@nl
type
label
Testing for oncogenic molecula ...... the clinic: are we there yet?
@en
Testing for oncogenic molecula ...... the clinic: are we there yet?
@nl
prefLabel
Testing for oncogenic molecula ...... the clinic: are we there yet?
@en
Testing for oncogenic molecula ...... the clinic: are we there yet?
@nl
P2860
P1476
Testing for oncogenic molecula ...... the clinic: are we there yet?
@en
P2093
Jiri Polivka
Martin Pesta
P2860
P304
P356
10.1586/14737159.2015.1110021
P50
P577
2015-11-11T00:00:00Z